Loading...

GRAIL, Inc. Common Stock

GRALV•NASDAQ
Healthcare
Medical - Diagnostics & Research
$18.63
$1.41(8.19%)

GRAIL, Inc. Common Stock (GRALV) Stock Overview

Explore GRAIL, Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 63.1/100

Key Financials

Market Cap579.4M
P/E RatioN/A
EPS (TTM)N/A
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$38.93

GRALV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GRAIL, Inc. Common Stock (GRALV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $38.93.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 579.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;